SUSS MicroTec's upcoming entry into the MDAX index put a very specific milestone on the calendar, and the later partnership with Ignite Next showed management leaning into a broader semiconductor ecosystem. Investors who held SUSS MicroTec over the past year are up 56.7%, including dividends. If you were deciding on 16 October 2025, what would you have needed to believe about these kinds of developments to justify buying before any of that was announced?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
This theme extends beyond SUSS MicroTec. See which of 10 top silver producer stocks may still merit a closer look.
The Two Narratives Investors Weighed On SUSS MicroTec
The shares cost €36.4 at the start of the period, and anyone looking at SUSS MicroTec had to choose between two very different stories about what came next.
On the optimistic side, the bull Narrative put Fair Value at €44.91. That view leaned on upcoming tools like MaskTrack Smart and new UV projection scanners, plus the Taiwan production site, to support revenue growth assumptions of 1.2% a year and a 9.4% profit margin in three years.
The bear Narrative pointed to a Fair Value of €30. It focused on shrinking China orders, a 13.2% decline in order intake and a book to bill ratio of 0.48, alongside margin pressure from ramp up costs, inventory write offs and concentrated customer exposure.
What The Results Changed For The SUSS MicroTec Narratives
SUSS MicroTec's MDAX inclusion and the Ignite Next partnership gave the bullish case fresh support, because both point to greater industry relevance and access to new ideas. The later Q2 2026 report pulled the other way. Revenue moved from €141.72m to €116.232m and net income declined from €15.96m to €6.28m, while net margin fell from 11.3% to 5.4%, so profitability progress in the optimistic thesis stayed unproven. Overall, the evidence cut both ways.
The key assumption that got tested was margin resilience. For another company, you would check whether net margin trends meaningfully track the story about new products, expansion plans or index moves before relying on those headlines.
What You Pay For In SUSS MicroTec After A 57% Run
Today SUSS MicroTec trades at €56.35. The selected bullish Narrative places its Fair Value above that level and roots the gap in how record orders, segment margins and the backlog might convert into future earnings power.
Before leaning on that higher figure, you would test whether customers keep turning large multi year commitments into sustained demand for advanced packaging and AI linked tools.
"The record order intake of €410m in the first half of 2026, already above full year 2025 levels and supported by three consecutive quarters of sequential growth, points to underappreciated operating leverage if SUSS MicroTec converts this larger funnel into higher throughput."
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for
Find Your Own Contrarian Opportunity
By the time a rally makes headlines, you are reading about returns someone else has already earned. Why not go straight to the source and look for your own contrarian opportunity? These three companies trade below our estimated value.
-
Company 1 - 41% below our estimate - supplies automation-ready lifting equipment as ports upgrade to electrified, smarter cargo handling.
-
Company 2 - 30% below our estimate - converts a large turbine and service backlog into executed onshore and offshore wind projects.
-
Company 3 - 15% below our estimate - shifts heavy investment in biosimilars and injectables into commercial products across multiple therapies.
Three companies from the same screener. Open every one of the 192 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SMHN.DE .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
